Fundz

Element Biosciences raises $175 million in upsized Series E funding led by Samsung Electronics to enhance global growth in genomic solutions.

PRIVATEJun 09, 2026

Amount Raised

$175 Million

Round Type

Series E

San DiegoBiotechnologyHealth CareGeneticsLife Science

Investors

Samsung Electronics

Description

Element Biosciences, Inc. announced an upsized Series E round of financing with $175 million from Samsung Electronics. The funding will accelerate commercialization of genomic and multiomic solutions and expand its global presence. This capital will advance development of technologies like AVITI and VITARI

Who to call at Element Biosciences, and when

A new round usually means Element Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Element Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Element Biosciences, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Element Biosciences

Location

San Diego, California, United States

About

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high-quality data, increase workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease run costs and capital costs while delivering high sequencing data quality.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Element Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Element Biosciences's next move

See what Strategic adds

Element Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.